GSK plc(GSK)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,902 of 2,961 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
GSK Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for GSK plc (GSK), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores GSK at 44.7/100 on a 32-signal composite quality model, placing it at rank #1,902 of 2,961 stocks — the bottom half of the AI-ranked universe. Top institutional holders of GSK by reported 13-F value include FMR, DODGE & COX, Fisher Asset Management, based on the most recent SEC filings. GSK trades on the NYSE exchange and files with the SEC under CIK 1131399. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GSK daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for GSK plc directly from SEC EDGAR. GSK plc's 13F Pro composite quality score has ranged between 44 and 48 since 2026, currently 44.7 — a stable long-term trajectory across 47 quarterly and live scoring snapshots.
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+4.1% YoYTotal Assets
+2.8% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $32.67B +4.1% | $31.38B +3.5% | $30.33B +3.4% | $29.32B +18.7% | $24.70B +1.4% | $24.35B |
| Total Assets | $61.12B +2.8% | $59.46B +0.8% | $59.01B -1.9% | $60.15B -24.0% | $79.10B -1.7% | $80.43B |
Get alerted when GSK's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for GSK plc including:
Top Institutional Holders of GSK
FMR LLC
$3.4B64,961,641 shDODGE & COX
$2.5B48,197,514 shFisher Asset Management, LLC
$1.9B35,722,792 shPRIMECAP MANAGEMENT CO/CA/
$1.3B25,182,068 shWELLINGTON MANAGEMENT GROUP LLP
$597.4M11,396,249 shJTC Employer Solutions Trusteee Ltd
$450.3M8,592,987 shMORGAN STANLEY
$401.4M7,657,562 shROYAL BANK OF CANADA
$397.8M7,588,928 shPRICE T ROWE ASSOCIATES INC /MD/
$362.9M6,923,642 shACADIAN ASSET MANAGEMENT LLC
$349.1M6,660,434 sh
| Fund | Value | Shares |
|---|---|---|
| FMR LLC | $3.4B | 64,961,641 |
| DODGE & COX | $2.5B | 48,197,514 |
| Fisher Asset Management, LLC | $1.9B | 35,722,792 |
| PRIMECAP MANAGEMENT CO/CA/ | $1.3B | 25,182,068 |
| WELLINGTON MANAGEMENT GROUP LLP | $597.4M | 11,396,249 |
| JTC Employer Solutions Trusteee Ltd | $450.3M | 8,592,987 |
| MORGAN STANLEY | $401.4M | 7,657,562 |
| ROYAL BANK OF CANADA | $397.8M | 7,588,928 |
| PRICE T ROWE ASSOCIATES INC /MD/ | $362.9M | 6,923,642 |
| ACADIAN ASSET MANAGEMENT LLC | $349.1M | 6,660,434 |
Companies Similar to GSK
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
ASTRAZENECA PLC
RIO TINTO PLC
KONINKLIJKE PHILIPS NV
NOVO NORDISK A S
Haleon plc
SAP SE
TAKEDA PHARMACEUTICAL CO LTD
PFIZER INC
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put GSK on your watchlist
Track score changes the day GSK plc files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is GSK a good stock to buy?
13F Pro's AI-powered analysis of GSK plc (GSK) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for GSK are available on the GSK stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. GSK is classified as a mega company.
Which hedge funds own GSK?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling GSK. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of GSK plc's investment landscape.